השוואת שיטות

	סקירה מבוססת PRISMA	סקירה מהירה
תחום	סיינטומטריה	סיינטומטריה
משפחה	Process / pipeline	Process / pipeline
שנת המקור	2009 (original PRISMA statement); updated 2020	2000s (rapidly adopted after 2005; Cochrane guidance 2020–2021)
הוגה השיטה	David Moher and PRISMA Group	Developed and formalised by health technology assessment agencies and the Cochrane Collaboration
סוג	Structured reporting framework for systematic reviews	Evidence synthesis review
מקור מכונן	Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71.	Garritty, C., Gartlehner, G., Nussbaumer-Streit, B., King, V. J., Hamel, C., Kamel, C., Affengruber, L., & Stevens, A. (2021). Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. Journal of Clinical Epidemiology, 130, 13–22.
כינויים	PRISMA review, PRISMA-guided systematic review, PRISMA 2020 review, PRISMA-compliant review	rapid evidence review, accelerated systematic review, rapid evidence assessment, REA
קשורות	5	5
תקציר	A PRISMA-based review is a systematic literature review conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Originally published by Moher et al. in 2009 and updated as PRISMA 2020 by Page et al., the framework specifies a 27-item checklist and a four-phase flow diagram covering identification, screening, eligibility, and inclusion — ensuring full transparency and reproducibility in the review process.	A rapid review is a streamlined form of systematic review that deliberately simplifies or omits certain steps — such as dual screening, exhaustive grey-literature search, or full risk-of-bias assessment — in order to deliver timely, policy-relevant evidence synthesis within weeks rather than years. It is increasingly used by health agencies, governments, and organisations facing urgent decision-making needs where a full systematic review is not feasible within the available time and resources.